OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Utilization and impact of SLGT2 inhibitors among diabetes patients in a nationally representative survey: Findings from NHANES 2013–2020
Tsung‐Hua Shen, Joel F. Farley
Journal of Diabetes and its Complications (2023) Vol. 37, Iss. 11, pp. 108625-108625
Closed Access | Times Cited: 5
Tsung‐Hua Shen, Joel F. Farley
Journal of Diabetes and its Complications (2023) Vol. 37, Iss. 11, pp. 108625-108625
Closed Access | Times Cited: 5
Showing 5 citing articles:
Comparative Effectiveness of Glucagon-Like Peptide-1 Receptor Agonists, Sodium-Glucose Cotransporter 2 Inhibitors, Dipeptidyl Peptidase-4 Inhibitors, and Sulfonylureas for Sight-Threatening Diabetic Retinopathy
Andrew J. Barkmeier, Jeph Herrin, Kavya Swarna, et al.
Ophthalmology Retina (2024) Vol. 8, Iss. 10, pp. 943-952
Closed Access | Times Cited: 4
Andrew J. Barkmeier, Jeph Herrin, Kavya Swarna, et al.
Ophthalmology Retina (2024) Vol. 8, Iss. 10, pp. 943-952
Closed Access | Times Cited: 4
Impact of Comprehensive Medication Reviews on Medicare Beneficiaries With Type 2 Diabetes
Tsung‐Hua Shen, Felix Cheuk Wun Ting, Shaquib Al Hasan, et al.
Journal of the American Geriatrics Society (2025)
Open Access
Tsung‐Hua Shen, Felix Cheuk Wun Ting, Shaquib Al Hasan, et al.
Journal of the American Geriatrics Society (2025)
Open Access
Sodium‐glucose co‐transporter‐2 inhibitors versus dipeptidyl peptidase‐4 inhibitors on major liver outcomes in metabolic dysfunction‐associated steatotic liver disease
Tsung‐Hua Shen, Elizabeth S. Aby, David M. Vock, et al.
Diabetes Obesity and Metabolism (2024) Vol. 26, Iss. 11, pp. 5116-5125
Open Access | Times Cited: 2
Tsung‐Hua Shen, Elizabeth S. Aby, David M. Vock, et al.
Diabetes Obesity and Metabolism (2024) Vol. 26, Iss. 11, pp. 5116-5125
Open Access | Times Cited: 2
Structural factors and their influence on the use of novel antidiabetic agents: Making the case for increased awareness and access to clinical pharmacy services
Olga Monika Trejos Kweyete, D. R. Woods, Joahn Okoumba, et al.
JACCP JOURNAL OF THE AMERICAN COLLEGE OF CLINICAL PHARMACY (2024) Vol. 8, Iss. 1, pp. 47-51
Closed Access
Olga Monika Trejos Kweyete, D. R. Woods, Joahn Okoumba, et al.
JACCP JOURNAL OF THE AMERICAN COLLEGE OF CLINICAL PHARMACY (2024) Vol. 8, Iss. 1, pp. 47-51
Closed Access
Sodium–Glucose Cotransporter-2 Inhibitors and Prevention of Adverse Kidney Outcomes in Type 2 Diabetes: A Clinical Multi-Ethnic Asian Cohort
Liang Feng, Zhong Hong Liew, Yong Mong Bee, et al.
Kidney Medicine (2024), pp. 100963-100963
Open Access
Liang Feng, Zhong Hong Liew, Yong Mong Bee, et al.
Kidney Medicine (2024), pp. 100963-100963
Open Access
